Detalhe da pesquisa
1.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242680
2.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
3.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
4.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
5.
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Mult Scler
; 29(6): 719-730, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012898
6.
External validation of a clinical prediction model in multiple sclerosis.
Mult Scler
; 29(2): 261-269, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448727
7.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433775
8.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
9.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
10.
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180218
11.
The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
J Int Neuropsychol Soc
; 28(1): 94-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563350
12.
Ethical use of off-label disease-modifying therapies for multiple sclerosis.
Mult Scler
; 27(9): 1403-1410, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304636
13.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
14.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
15.
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.
Mult Scler
; 26(13): 1765-1774, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668127
16.
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events.
Stroke
; 50(4): 853-858, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852970
17.
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(4): 458-468, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636699
18.
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.
Mult Scler
; 30(1): 3-6, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850437
19.
Multiple Sclerosis.
Semin Neurol
; 38(2): 212-225, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791948
20.
Gadolinium effect on thalamus and whole brain tissue segmentation.
Neuroradiology
; 60(11): 1167-1173, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128599